August 2016
Update on the Cancer Epigenetics Clinical Trials Database
The Cancer Epigenetics Society has continued expanding its cancer epigenetic drug clinical trial repository which now covers 500+ clinical trials. These include most if not all reported completed, ongoing, and recruiting cancer clinical trials on [...]
June 2016
Empowering Cancer patients
As a member of the US National Coalition for Cancer Survivorship (NCCS), the Cancer Epigenetics Society asks our members in the States with interest in cancer treatment and survival to help support cancer advocacy in [...]
Patient’s resources at CES go local, II
We have continued to expand our country-specific resources to better cater to the needs of local patients. We now provide resources for Austria, Bulgaria, Canada, Cyprus, Ecuador, France, Greece, Nicaragua, Peru, Portugal, Russia, Slovakia, Turkey, [...]
The cancer epigenetics of imprinting
Aberrations in the epigenetic phenomenon known as imprinting is a highly frequent early event in tumorigenesis (initiation of cancer) of a large number of tumors including acute myeloid leukemia (AML), Barrett's esophagus, breast cancer, chronic [...]
After cancer prevention, aspirin steps up to the plate of cancer treatment?!
We recently reported that frequent low-dose intake of aspirin reduces the risk of developing colorectal and bile duct cancers (read it here). Now a new study from Norway shows that taking aspirin after cancer diagnosis [...]
May 2016
Walking or running away from cancer!
Regular exercise is known to improve cardiovascular function and to reduce the risk or lessen the impact of stress, depression, high blood pressure, stroke, arthritis, osteoporosis, back pain, as well as obesity and certain forms [...]